The Increasing Importance of Manufacturability in API Development
Antibody + Drug + Third Party, Antibody + siRNAASO + Third Party
AI in Pharmaceutical Manufacturing Operations
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Real-World Data and Real-World Evidence: Shaping the Future of Clinical Research
American healthcare generates a staggering volume of patient data every day electronic health records claims pharmacy fills laboratory results registries and increasingly sensor streams Congress recognised the opportunity in directing the FDA through the st Century Cures Act to build
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus
Phycocyanobilin a bioactive compound derived from Arthrospira platensis C was investigated for its potential role in systemic lupus erythematosus SLE based on its structural similarity to bilirubin
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Autoantigen-Specific Biomarkers as Effector-Driven Therapeutic Targets
Lakshmi
For decades, autoantibodies were read as clues — signposts pointing to a disease already underway. A new generation of science is asking a sharper question: what if the biomarker is not just a s...
-
2
Ensuring Patient Safety: The Essentials of Drug Safety & Pharmacovigilance
Kate Williamson
This article explores the critical role of drug safety and pharmacovigilance in ensuring patient safety, covering processes from preclinical studies to post-market surveillance, challenges like underr...
-
3
Advances in Regenerative Medicine: Stem Cells and Tissue Engineering
Harry Callum
Forming new ideas of the regenerative medicine, which principles are based on cell and tissue engineering, bring changes in approach to the treatment. There is also an awareness of the embryonic stem...
-
4
Embracing AI to Revolutionize Drug Safety: A Call for Modernizing Pharmacovigilance Practices
Pramod Kumar
Pharmacovigilance is vital for protecting patients, but traditional approaches fail to address diverse populations and real-world complexities. This article highlights how AI, particularly LLMs and Ge...
-
5
How Eco-Friendly Clinical Trial Materials are Revolutionizing Research?
Kate Williamson
This article explores the transformative impact of eco-friendly clinical trial materials on research, highlighting the environmental challenges of traditional trials, the adoption of sustainable alter...
press releasesRead more...
Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy
Exegenesis Bio and Modalis Therapeutics Corporation TOKYO Modalis today announced that they have signed a research collaboration and license agreement to advance MDL
Nutromics receives FDA Breakthrough Device Designation
Nutromics is building a wearable labonapatch for continuous molecular monitoring Today the company has announced that the FDA has granted Breakthrough Device Designation BDD for its first product in development a wearable for vancomycin therapeutic drug monitoring
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
EpilepsyGTx a biotechnology company developing gene therapies for refractory epilepsy and Viralgen a leading contract development and manufacturing organization CDMO specialising in recombinant
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
Revvity Inc NYSE RVTY today announced it has entered into a definitive agreement to acquire Human Cell Design HCD a Francebased biotechnology company specializing in human cell models and preclinical research solutions
Events Read more...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWSRead more...
ABEC Opens New Manufacturing Facility in North Carolina
ABEC has opened a new manufacturing facility in Wilson North Carolina expanding its global production network and strengthening support for the growing biopharmaceutical industry
Biora Therapeutics to Initiate First Human Study of BioJet Oral Biologic Delivery Capsule
Biora Therapeutics plans to begin its first human clinical study of BioJet an ingestible capsule designed to deliver medicines directly into the small intestine using liquid jet technology
Lotus Neuro launches to advance targeted therapies across the blood-brain barrier
Lotus Neuro a clinicalstage biotechnology company focused on neurological diseases has announced its public launch The company combines focused ultrasound with existing therapeutic approaches to improve the delivery of medicines across the bloodbrain barrier BBB
Sobi receives US FDA Fast Track designation for pacritinib in VEXAS syndrome
Sobi North America the North American affiliate of Swedish Orphan Biovitrum Sobi has announced that the US Food and Drug Administration FDA has granted Fast Track designation to pacritinib for the treatment of VEXAS syndrome
Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement
Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001
RiboX Therapeutics has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for RXRG an investigational treatment
